phenprocoumon   Click here for help

GtoPdb Ligand ID: 6839

Synonyms: Liquamar® | phenprocoumarol
Approved drug
phenprocoumon is an approved drug (FDA (1957))
Compound class: Synthetic organic
Comment: Vitamin K epoxide reductase complex subunit 1 isoform 1 inhibitor. The INN-designated compound is a racemic mixture of two enantiomers.The structure shown here does not specify stereochemistry and represents the mixture.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: phenprocoumon

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 50.44
Molecular weight 280.11
XLogP 4.99
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC(c1c(=O)oc2c(c1O)cccc2)c1ccccc1
Isomeric SMILES CCC(c1c(=O)oc2c(c1O)cccc2)c1ccccc1
InChI InChI=1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3
InChI Key DQDAYGNAKTZFIW-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Used for the prevention and treatment of thromboembolic disease; venous thrombosis, thromboembolism, pulmonary embolism and prevention of ischemic stroke in patients with atrial fibrillation. Marketing of this drug in the US has been discontinued. Individual national approval agencies may continue to grant marketing authorisation.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Coumarin derivative that acts as a long acting oral anticoagulant, acting to deplete the reduced form of vitamin K essential to the clotting process